Corrigendum to moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy [Life Sci. 312 (2023)/121,210]
Life Sciences · 2026-09 · 400 · 124487
DOI: 10.1016/j.lfs.2026.124487 ↗Kurz gefasst
Korrektur in der Zeitschrift Life Sciences, 2026-09. Verfasst von Shaimaa S El-Sayed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. Electronic address: samar_rezq@yahoo.com.
- Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Zitieren
APA
El-Sayed, S. S., Rezq, S., Alsemeh, A. E., & Mahmoud, M. F. (2026). Corrigendum to moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy [Life Sci. 312 (2023)/121,210]. Life Sciences, 400, 124487. https://doi.org/10.1016/j.lfs.2026.124487
Vancouver
El-Sayed SS, Rezq S, Alsemeh AE, Mahmoud MF. Corrigendum to moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy [Life Sci. 312 (2023)/121,210]. Life Sciences. 2026;400:124487. doi:10.1016/j.lfs.2026.124487
BibTeX
@article{ElSayed2026,
author = {El-Sayed, Shaimaa S and Rezq, Samar and Alsemeh, Amira Ebrahim and Mahmoud, Mona F},
title = {Corrigendum to moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy [Life Sci. 312 (2023)/121,210]},
journal = {Life Sciences},
year = {2026},
volume = {400},
pages = {124487},
doi = {10.1016/j.lfs.2026.124487}
}
EUVIMED